US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist

25.600
-0.260-1.01%

Close Dec 30 16:00 ET

25.600
0.0000.00%

Post 16:00 ET

2.68BMarket Cap-11.58P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

73.39%-12.5M

-84.20%-53.98M

-71.36%-54.6M

-1,424.13%-141.22M

-33.07M

-46.98M

-29.31M

-31.86M

136.14%10.67M

-301.92%-29.51M

Net income from continuing operations

64.68%-16.65M

-1.87%-39.01M

-123.16%-93.77M

-681.73%-176.94M

---49.5M

---47.13M

---38.29M

---42.02M

45.83%-22.63M

-490.94%-41.79M

Operating gains losses

-717.03%-3.91M

-2,161.14%-8.7M

1,231.02%41.37M

-51.56%5.23M

--1.06M

--634K

--422K

--3.11M

1,410.81%10.79M

-2,688.05%-823K

Depreciation and amortization

100.00%28K

46.15%19K

66.67%15K

444.44%49K

--13K

--14K

--13K

--9K

80.00%9K

306.52%5K

Other non cash items

150.00%5K

100.00%2K

-50.00%1K

-99.93%6K

--1K

--2K

--1K

--2K

8.61%8.01M

1,717.51%7.38M

Change In working capital

100.48%28K

-587.47%-14.59M

-1,647.76%-10.14M

-43.45%5.87M

--9.34M

---5.89M

--2.99M

---580K

132.06%10.37M

788.31%4.47M

-Change in prepaid assets

83.84%-493K

-269.36%-9.23M

167.66%956K

196.32%4.03M

--3.04M

---3.05M

--5.45M

---1.41M

20.01%-4.19M

-213.47%-5.23M

-Change in payables and accrued expense

2,056.07%2.31M

-314.29%-3.07M

-337.72%-9.69M

372.35%10.54M

--7.1M

--107K

---742K

--4.08M

-139.89%-3.87M

851.52%9.7M

-Change in other working capital

39.29%-1.79M

-32.73%-2.28M

56.81%-1.4M

-147.24%-8.71M

---802K

---2.94M

---1.72M

---3.24M

--18.43M

----

Cash from discontinued investing activities

Operating cash flow

73.39%-12.5M

-84.20%-53.98M

-71.36%-54.6M

-1,424.13%-141.22M

---33.07M

---46.98M

---29.31M

---31.86M

136.14%10.67M

-301.92%-29.51M

Investing cash flow

Cash flow from continuing investing activities

-733.33%-75K

-4,080.00%-209K

-5,400.00%-385K

89.14%-24K

-3K

-9K

-5K

-7K

-820.83%-221K

-50.10%-24K

Net PPE purchase and sale

-733.33%-75K

-4,080.00%-209K

-5,400.00%-385K

89.14%-24K

---3K

---9K

---5K

---7K

-820.83%-221K

-50.10%-24K

Cash from discontinued investing activities

Investing cash flow

-733.33%-75K

-4,080.00%-209K

-5,400.00%-385K

89.14%-24K

---3K

---9K

---5K

---7K

-820.83%-221K

-50.10%-24K

Financing cash flow

Cash flow from continuing financing activities

-68.82%58K

-26.46%4.66M

8,185.12%198.18M

-97.73%8.91M

186K

6.33M

2.39M

362.68%391.91M

508.37%84.7M

Net issuance payments of debt

----

--0

----

--747K

--0

Net common stock issuance

--0

--190.48M

--0

368.63%396.95M

--84.7M

Proceeds from stock option exercised by employees

-68.82%58K

-26.46%4.66M

284.74%9.2M

--8.91M

--0

--186K

--6.33M

--2.39M

--0

Net other financing activities

--0

---1.5M

----

---5.79M

----

Cash from discontinued financing activities

Financing cash flow

-68.82%58K

-26.46%4.66M

8,185.12%198.18M

-97.73%8.91M

--0

--186K

--6.33M

--2.39M

362.68%391.91M

508.37%84.7M

Net cash flow

Beginning cash position

3.36%430.71M

9.03%481.15M

-27.21%340.45M

677.85%467.73M

--368.31M

--416.71M

--441.31M

--467.73M

523.38%60.13M

213.70%9.65M

Current changes in cash

73.25%-12.52M

-115.57%-49.53M

585.76%143.19M

-132.89%-132.33M

---33.08M

---46.8M

---22.98M

---29.48M

629.32%402.35M

740.43%55.17M

Effect of exchange rate changes

383.75%4.54M

44.23%-909K

-181.52%-2.5M

-3.73%5.05M

--5.22M

---1.6M

---1.63M

--3.06M

212.06%5.25M

-15,964.44%-4.68M

End cash Position

14.78%422.73M

3.36%430.71M

9.03%481.15M

-27.21%340.45M

--340.45M

--368.31M

--416.71M

--441.31M

677.85%467.73M

521.92%60.13M

Free cash flow

73.23%-12.58M

-84.88%-54.19M

-72.54%-54.99M

-1,452.37%-141.24M

---33.08M

---46.99M

---29.31M

---31.87M

135.36%10.44M

-301.37%-29.54M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	73.39%-12.5M	-84.20%-53.98M	-71.36%-54.6M	-1,424.13%-141.22M	-33.07M	-46.98M	-29.31M	-31.86M	136.14%10.67M	-301.92%-29.51M
Net income from continuing operations	64.68%-16.65M	-1.87%-39.01M	-123.16%-93.77M	-681.73%-176.94M	---49.5M	---47.13M	---38.29M	---42.02M	45.83%-22.63M	-490.94%-41.79M
Operating gains losses	-717.03%-3.91M	-2,161.14%-8.7M	1,231.02%41.37M	-51.56%5.23M	--1.06M	--634K	--422K	--3.11M	1,410.81%10.79M	-2,688.05%-823K
Depreciation and amortization	100.00%28K	46.15%19K	66.67%15K	444.44%49K	--13K	--14K	--13K	--9K	80.00%9K	306.52%5K
Other non cash items	150.00%5K	100.00%2K	-50.00%1K	-99.93%6K	--1K	--2K	--1K	--2K	8.61%8.01M	1,717.51%7.38M
Change In working capital	100.48%28K	-587.47%-14.59M	-1,647.76%-10.14M	-43.45%5.87M	--9.34M	---5.89M	--2.99M	---580K	132.06%10.37M	788.31%4.47M
-Change in prepaid assets	83.84%-493K	-269.36%-9.23M	167.66%956K	196.32%4.03M	--3.04M	---3.05M	--5.45M	---1.41M	20.01%-4.19M	-213.47%-5.23M
-Change in payables and accrued expense	2,056.07%2.31M	-314.29%-3.07M	-337.72%-9.69M	372.35%10.54M	--7.1M	--107K	---742K	--4.08M	-139.89%-3.87M	851.52%9.7M
-Change in other working capital	39.29%-1.79M	-32.73%-2.28M	56.81%-1.4M	-147.24%-8.71M	---802K	---2.94M	---1.72M	---3.24M	--18.43M	----
Cash from discontinued investing activities
Operating cash flow	73.39%-12.5M	-84.20%-53.98M	-71.36%-54.6M	-1,424.13%-141.22M	---33.07M	---46.98M	---29.31M	---31.86M	136.14%10.67M	-301.92%-29.51M
Investing cash flow
Cash flow from continuing investing activities	-733.33%-75K	-4,080.00%-209K	-5,400.00%-385K	89.14%-24K	-3K	-9K	-5K	-7K	-820.83%-221K	-50.10%-24K
Net PPE purchase and sale	-733.33%-75K	-4,080.00%-209K	-5,400.00%-385K	89.14%-24K	---3K	---9K	---5K	---7K	-820.83%-221K	-50.10%-24K
Cash from discontinued investing activities
Investing cash flow	-733.33%-75K	-4,080.00%-209K	-5,400.00%-385K	89.14%-24K	---3K	---9K	---5K	---7K	-820.83%-221K	-50.10%-24K
Financing cash flow
Cash flow from continuing financing activities	-68.82%58K	-26.46%4.66M	8,185.12%198.18M	-97.73%8.91M	0	186K	6.33M	2.39M	362.68%391.91M	508.37%84.7M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--747K	--0
Net common stock issuance	--0	--0	--190.48M	--0	--0	--0	--0	--0	368.63%396.95M	--84.7M
Proceeds from stock option exercised by employees	-68.82%58K	-26.46%4.66M	284.74%9.2M	--8.91M	--0	--186K	--6.33M	--2.39M	--0	--0
Net other financing activities	--0	--0	---1.5M	----	----	----	----	----	---5.79M	----
Cash from discontinued financing activities
Financing cash flow	-68.82%58K	-26.46%4.66M	8,185.12%198.18M	-97.73%8.91M	--0	--186K	--6.33M	--2.39M	362.68%391.91M	508.37%84.7M
Net cash flow
Beginning cash position	3.36%430.71M	9.03%481.15M	-27.21%340.45M	677.85%467.73M	--368.31M	--416.71M	--441.31M	--467.73M	523.38%60.13M	213.70%9.65M
Current changes in cash	73.25%-12.52M	-115.57%-49.53M	585.76%143.19M	-132.89%-132.33M	---33.08M	---46.8M	---22.98M	---29.48M	629.32%402.35M	740.43%55.17M
Effect of exchange rate changes	383.75%4.54M	44.23%-909K	-181.52%-2.5M	-3.73%5.05M	--5.22M	---1.6M	---1.63M	--3.06M	212.06%5.25M	-15,964.44%-4.68M
End cash Position	14.78%422.73M	3.36%430.71M	9.03%481.15M	-27.21%340.45M	--340.45M	--368.31M	--416.71M	--441.31M	677.85%467.73M	521.92%60.13M
Free cash flow	73.23%-12.58M	-84.88%-54.19M	-72.54%-54.99M	-1,452.37%-141.24M	---33.08M	---46.99M	---29.31M	---31.87M	135.36%10.44M	-301.37%-29.54M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data